MedPath

Effect of Dapagliflozin in patients with type 2 daibetes mellitus

Not Applicable
Conditions
Type 2 diabetes mellitus
Registration Number
JPRN-UMIN000014922
Lead Sponsor
Iwasaki Naika Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1. Type 1 diabetes 2. Patients with severe renal failure or liver dysfunction 3. Patients with drug allergy for ipraglifrozin 4. Patients with history of diabetec ketosis 5. Patients with shick day

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The predictive parameters for the effect on Dapaglyflozin
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath